In The News
ScienceDaily | January 6, 2017
Elevated levels of the brain protein tau following concussion are associated with a longer recovery period and may serve as a marker to help physicians determine an athlete's readiness to return to play, report investigators.
Science | January 6, 2017
In athletes who suffered a concussion, a protein in their blood may be able to predict when they can return to action.
Z Living| january 3, 2017
Carrie Fisher’s recent heart failure (in addition to the passing of her iconic mother Debbie Reynolds) reminds us all how much this country struggles with heart disease, where it's the leading cause of death. In a fascinating attempt to curb this issue, one Massachusetts-based company is creating
Boston Business Journal | December 20, 2016
A Boston Business Journal survey of the 28 life science companies that got state tax breaks this year in exchange for vows to create jobs found that at least nine achieved their goals, Quanterix is one of them, while five ended up declining their awards.
WGBH | December 13, 2016
Diagnosing a concussion is less than an exact science, but that could change with new technology being developed by a local company. WGBH News’ Stephanie Leydon (@stephanieleydon) has details of a blood test that could improve how this type of head trauma is diagnosed.
Clinical Lab Products | December 13, 2016
Quanterix Corp, Lexington, Mass, will join forces with UmanDiagnostics AB, Umeå, Sweden, to provide commercial access to an ultrasensitive single molecule array (Simoa) assay for the detection of neurofilament light (Nf-light) in blood specimens.
Fortune | December 12, 2016
A Massachusetts company looks for tiny disease markers in a sea of blood.
Medical Device+Diagnostic Industry (MD+DI) | December 1, 2016
Quanterix's Simoa instrument, which can detect low concentrations of protein in a sample of blood, offers the potential for earlier diagnosis of disease.
Boston Business Journal | November 21, 2016
Our CEO Kevin Hrusovsky was named one of the Boston Business Journal's 2017 Innovation All-Stars
Multiple Sclerosis News Today | November 17, 2016
Quanterix and UmanDiagnostics are working to advance an assay capable of detecting neuron damage in a blood sample